Results 141 to 150 of about 74,793 (347)
The Effect of Self-Hypnosis on Exam Anxiety and Stress Among University Students
Melike Demir Doğan +58 more
openalex +1 more source
Summary The world‐wide prevalence of insomnia disorder reaches up to 10% of the adult population. Women are more often afflicted than men, and insomnia disorder is a risk factor for somatic and mental illness, especially depression and anxiety disorders.
Dieter Riemann +13 more
wiley +1 more source
Hypnosis for anaesthetists: a systematic review and meta-analyses. [PDF]
Summary Introduction Therapeutic hypnosis appears to offer psychological and physiological benefits in various medical fields, but despite increasing interest, its value for anaesthesia remains inconclusive. Methods We searched for studies of any design in which hypnosis was used for any intervention requiring the presence of an anaesthetist, alone or ...
Lahoud MJ, Gurary ST, Elia N.
europepmc +2 more sources
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont +5 more
wiley +1 more source
The Legal Self: Executive processes and legal theory [PDF]
When laws or legal principles mention mental states such as intentions to form a contract, knowledge of risk, or purposely causing a death, what parts of the brain are they speaking about?
Hirstein, William, Sifferd, Katrina
core
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng +3 more
wiley +1 more source
The Effect of Hypnosis on The Level of Anniversity of Women With HIV/AIDS
Hesti Wiji Utami, Wiwin Mintarsih
openalex +2 more sources
ABSTRACT Daridorexant, a dual orexin receptor antagonist, is approved for the treatment of insomnia disorder in adults. Approximately 30%–35% of patients with insomnia disorder also have obstructive sleep apnoea (OSA) of any severity. It is unclear whether sleep medications provide safe and effective treatment for insomnia in these patients.
Christopher J. Lettieri +8 more
wiley +1 more source

